Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update.
Discov Med
; 27(148): 167-170, 2019 03.
Article
en En
| MEDLINE
| ID: mdl-31095926
ABSTRACT
The understanding of genetic alterations that drive non-small cell lung cancer (NSCLC) is evolving. As many of these molecularly-defined subtypes are potentially actionable, new strategies in molecular diagnostics and targeted therapies in NSCLC to detect and treat them are being explored. At the International Association for Study of Lung Cancer 19th World Conference, several abstracts and oral presentations related to this topic. In this report, we discuss some of these updates.
Buscar en Google
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Carcinoma de Pulmón de Células no Pequeñas
/
Neoplasias Pulmonares
Tipo de estudio:
Diagnostic_studies
Límite:
Humans
Idioma:
En
Revista:
Discov Med
Año:
2019
Tipo del documento:
Article
País de afiliación:
Estados Unidos